Vaccine against COVID-19

©The Author 2021. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/)..

The COVID-19 pandemic has produced a huge health, economic and psychological collapse in our society. Health workers have had to face one of the greatest challenges in history, trying to show the population how to deal with this disease. We have learned that vaccines are the great instrument for the fight against infectious diseases and a large number of them began to appear, not as a product of chance but as a product of the enormous progress experienced in recent years with vaccines against new infectious diseases, against other diseases such as Alzheimer's and especially against cancer. All this knowledge has been applied to this disease. Practitioners lamented the little information available to them when asked questions from patients. This document wanted to be a response to these concerns, with a scientific desire, with evidence that put aside unverified data and hoaxes. Faced with an avalanche of information, most of it without the appropriate "peer review" as indicated in the introduction, any publication becomes obsolete at the time of publication, and we opted for an "online" publication, with the incorporation of versions. This online publication has been published in the documents of Spanish Society of Chemotherapy, at https://seq.es/vacunacion-covid-19.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:34

Enthalten in:

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 34(2021), 6 vom: 27. Dez., Seite 559-598

Sprache:

Spanisch

Weiterer Titel:

Vacuna frente al COVID-19

Beteiligte Personen:

Picazo, J J [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
COVID-19 Vaccines
Effectiveness-safety
Journal Article
Review
SARS-CoV-2
Vaccines
Variants

Anmerkungen:

Date Completed 26.11.2021

Date Revised 08.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.37201/req/085.2021

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327276517